NFKB1 and lung carcinoma: ANXA2 is also associated with several classical cancer-related pathways such as PI3K/Akt signaling, Akt/mTOR signaling, and NF-κB signaling pathways in lung cancer, gastric cancer, and GBM respectively [34, 45, 46].